Prognostic significance of lymph node ratio in adenocarcinoma of the esophagogastric junction: a study of patients after radical gastrectomy

淋巴结比率在食管胃交界处腺癌预后中的意义:一项根治性胃切除术后患者的研究

阅读:2

Abstract

OBJECTIVE: The incidence of adenocarcinoma of the esophagogastric junction (AEG) is increasing worldwide. Lymph node metastasis is a crucial prognostic factor in AEG patients. This study investigated the utility of lymph node ratio (LNR, the ratio of metastatic nodes to the total number of examined lymph nodes) in predicting the prognosis of AEG patients. PATIENTS AND METHODS: The study conducted a retrospective analysis of 257 patients with AEG who underwent radical gastrectomy with lymphadenectomy. The patients were categorized into low-LNR (L-LNR) and high-LNR (H-LNR) groups, and their corresponding clinicopathological characteristics and survival rates were compared. Receiver Operating Characteristic (ROC) curves were generated to evaluate the sensitivity and specificity of LNR. RESULTS: The cutoff value for dividing the L-LNR group, and the H-LNR group was 0.20. In the L-LNR group, the 1, 3, and 5-year disease-free survival (DFS) rates and overall survival (OS) rates were higher than H-LNR group. Patients in the L-LNR group had better prognoses than those in the H-LNR group (P<0.001). Univariate analysis identified that vascular invasion, lymphatic invasion and LNR were risk factors for DFS and OS. Additionally, multivariate analysis demonstrated that LNR was independent risk factor for DFS and OS. In the subgroup analysis stratified by TNM stage, patients in the L-LNR group demonstrated better DFS and OS compared to those in the H-LNR group. The ROC curve identified that the LNR has good sensitivity and specificity for prognostic prediction in AEG patients, especially in stage III. CONCLUSIONS: Patients with LNR greater than 0.2 experienced significantly shorter OS and DFS in patients with AEG, especially in TNM stage III.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。